Clinical and epidemiological characteristics of testicular cancer and its therapeutic management
Keywords:
TESTIS, ADENOLYMPHOMA, ORCHIECTOMY.Abstract
Introduction: among the neoplasms affecting males, testicular germ cell tumors account for 0,5-1 %. In the last four decades there has been an increase in the incidence of testicular cancer from 5,7 to 6.8 cases per 100,000 inhabitants.
Objective: to characterize the epidemiological clinical behavior and therapeutic management of patients with testicular cancer in Pinar del Rio from 2010 to 2019.
Methods: an observational, descriptive, retrospective study was carried out in Pinar del Río province from 2010 to 2019 which comprised the total number of patients diagnosed and treated for testicular cancer registered in the Cancer Care Center (III Congress). A data base was made where qualitative variables were expressed in absolute frequencies and relative frequencies in percentages.
Results: ages between 31 and 40 predominated (29,5 %) and white race (94,1 %); the most frequent reason for consultation was testicular enlargement (70,6 %). Histologically, seminoma predominated (58,8 %), with predominance of clinical stages IA and IB. There was a stable disease response in 41,2 %.
Conclusions: testicular tumors occurred more frequently in the fourth decade of life attending consultation for testicular enlargement; the most frequent histological type were seminomas in clinical stages IA and IB and in most of them there was a stable response of the disease.
Downloads
References
1. Notario Barba V, Carbayo García JJ, Magallanes Gamboa JO. Tumoración testicular. Rev Clin Med Farm [Internet]. 2016 [citado: 03/06/2021]; 9(2): 131-134. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-695X2016000200013
2. Savón Moiran L, Viel Reyes H, Guilarte Harriete M. Generalidades sobre cáncer de testículo. Rev Inf Cient [Internet]. 2015 [citado: 03/06/2021]; 91(3): 565-576. Disponible en: http://www.revinfcientifica.sld.cu/index.php/ric/article/view/234
3. Garolla A, De Toni L, Bottacin A, Valente U, De Rocco Ponce M, Di Nisio A, et al. Human papillomavirus prophylactic vaccination improves reproductive outcome in infertile patients with HPV semen infection: a retrospective study. Sci Rep [Internet]. 2018 [citado: 11/02/2020]; 8(912). Disponible en: https://www.nature.com/articles/s41598-018-19369-z
4. Boccellino M, Vanacore D, Zappavigna S, Cavaliere C, Rossetti S, D'Aniello C, et al. Testicular cancer from diagnosis to epigenetic factors. Oncotarget [Internet]. 2017 [citado: 03/06/2021]; 8(61): 104654-104663. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29262668/
5. Williamson SR, Delahunt B, Magi-Galluzzi C, Algaba F, Egevad L, Ulbright TM, et al. Members of the ISUP testicular tumour panel. The World Health Organization 2016 classification of testicular germ cell tumours: A review and update from the International Society of Urological Pathology Testis Consultation Panel. Histopathology [Internet]. 2017 [citado: 11/02/2020]; 70(3): 335-346. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27747907
6. Gurolla A, Vitagliano A, Muscianisi F, Valente U, Ghezzi M, Andrisani A, et al. Role of Viral Infections in Testicular Cancer Etiology: Evidence From a Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) [Internet]. 2019 [citado: 03/06/2020]; 10: 355. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584824/
7. Rodríguez Moreno JF. Cáncer de testículo [Internet]. SEOM. Madrid; 2020 [citado: 14/01/2020]. Disponible en: https://seom.org/info-sobre-el-cancer/testiculo?start=0
8. Grande G, Milardi D, Martini M, Cenci T, Gulino G, Mancini F, et al. Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. Front Endocrinol (Lausanne) [Internet]. 2019 [citado: 03/06/2020]; 10: 619. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31572301
9. Zachary L. Testicular Cancer Epidemiology, Diagnosis, and Management. Med Clin N Am [Internet]. 2018 [citado:03/06/2020]; 102(2): 251-264. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29406056/
10. Cuba, Ministerio de Salud Pública. Anuario estadístico [Internet].La Habana: MINSAP; 2018. [citado: 03/06/2020] Disponible en: https://salud.msp.gob.cu/portfolio/anuario-estadistico/
11. INSTITUTO NACIONAL DE ONCOLOGÍA. TRATAMIENTO DEL CÁNCER DE TESTÍCULO [INTERNET]. NIH; 2018. [CITADO: 03/06/2020]. DISPONIBLE EN: HTTPS://WWW.CANCER.GOV/ESPANOL/TIPOS/TESTICULO/PRO/TRATAMIENTO-TESTICULO-PDQ
12. Reginelli A, D'Andrea A, Clemente A, Izzo A, Urraro F, Scala F, et al. Does multiparametric US improve diagnostic accuracy in the characterization of small testicular masses? Gland Surg [Internet]. 2019 [citado: 23/09/2020]; 8(3): 136-41. Disponible en: https://gs.amegroups.com/article/view/25117/25403
13. Palumbo C, Mistretta FA, Mazzone E, Knipper S, Tian Z, Perrotte P, et al. Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors. Clin Genito urin Cancer [Internet]. 2019 [citado: 29/03/2020]; 17(5): 1026-35. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31378580
14. Nason GJ, Leao R, Hamilton RJ. Active surveillance in stage 1 disease: standard of care independent of risk factors? CurrOpinUrol [Internet]. 2020 [citado: 12/09/2020]; 30(2):245-50. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31834082/
15. Gurrola Ortega A, Sánchez Núñez JE, Rivera Astorga H, Magaña González JE, Sarabia Estrada RC, Garduño Arteaga LM, et al. Cáncer testicular: incidencia, epidemiología y etiología. Cinco años de experiencia en el Hospital General de México Dr. Eduardo Liceaga. Rev Mex Urol [Internet]. 2018 [citado: 12/09/2020]; 78(5): 347-53. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=83278
16. Oosterhuis JW, Looijenga LHJ. Human germ cell tumours from a developmental perspective. Nat Rev Cancer [Internet]. 2019 [citado: 09/12/2020]; 19(9): 522-37. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31413324/
17. Cullen M, Huddart R, Joffe J, Gardiner D, Maynard L, Hutton P, et al. The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis. Eur Urol [Internet]. 2020 [citado: 03/06/2020]; 77(3):344-351. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31901440/
18. Aparicio J, Sánchez Muñoz A, Ochenduszko S, Gumà J, Fernández Aramburo A, García Del Muro X, et al. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group. J Urol [Internet]. 2019 [citado: 05/08/2020]; 202(4): 742-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31163007/
19. Tremeau L, Mottet N. Management of residual masses of testis germ cell tumors. Bull Cancer [Internet]. 2020 [citado: 11/02/2021]; 107(2): 215-223. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31882267/
20. Fontes-Sousa M, Lobo J, Magalhães H, et al. Clinical implications of the American Joint Committee on Cancer (AJCC) 8th edition update in seminoma pT1 subclassification. BMC Urol [Internet]. 2020 [citado:20/4/2021]; 20(127). Disponible en: https://bmcurol.biomedcentral.com/articles/10.1186/s12894-020-00682-7
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
